BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11240443)

  • 1. Low HDL-cholesterol: a component of the metabolic syndrome only in the presence of fasting hypertriglyceridemia in type 2 diabetic patients.
    Bo S; Cavallo-Perin P; Gentile L; Repetti E; Pagano G
    Diabetes Metab; 2001 Feb; 27(1):31-5. PubMed ID: 11240443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular morbidity and mortality associated with the metabolic syndrome.
    Isomaa B; Almgren P; Tuomi T; Forsén B; Lahti K; Nissén M; Taskinen MR; Groop L
    Diabetes Care; 2001 Apr; 24(4):683-9. PubMed ID: 11315831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.
    Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Cholesterol Uptake Capacity in Patients with Hypertriglyceridemia and Diabetes Mellitus.
    Seto Y; Nagao M; Iino T; Harada A; Murakami K; Miwa K; Shinohara M; Nishimori M; Yoshikawa S; Asakura J; Fujioka T; Ishida T; Hirata KI; Toh R
    J Appl Lab Med; 2024 Jul; 9(4):728-740. PubMed ID: 38574000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).
    Mohan V; Deepa R; Pradeepa R; Vimaleswaran KS; Mohan A; Velmurugan K; Radha V
    Metabolism; 2005 Apr; 54(4):476-81. PubMed ID: 15798954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of triglycerides for other metabolic parameters in the familial metabolic syndrome].
    Metzler W; Fücker K; Schwanebeck U; Hanefeld M; Julius U; Kindel B; Fischer S
    Dtsch Med Wochenschr; 2003 Sep; 128(38):1941-6. PubMed ID: 14502445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of socioeconomic status on cardiovascular risk factors in African-Americans at high risk for type II diabetes. Implications for syndrome X.
    Gaillard TR; Schuster DP; Bossetti BM; Green PA; Osei K
    Diabetes Care; 1997 May; 20(5):745-52. PubMed ID: 9135936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated low HDL cholesterol: an insulin-resistant state only in the presence of fasting hypertriglyceridemia.
    Tai ES; Emmanuel SC; Chew SK; Tan BY; Tan CE
    Diabetes; 1999 May; 48(5):1088-92. PubMed ID: 10331414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance in type 2 (non-insulin-dependent) diabetic patients with hypertriglyceridaemia.
    Widén E; Ekstrand A; Saloranta C; Franssila-Kallunki A; Eriksson J; Schalin-Jäntti C; Groop L
    Diabetologia; 1992 Dec; 35(12):1140-5. PubMed ID: 1478365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between insulin resistance and risk factors for cardiovascular disease in Japanese non-insulin-dependent diabetic patients.
    Wasada T; Kuroki H; Arii H; Maruyama A; Aoki K; Katsumori K; Saito S; Hanada H; Omori Y
    Diabetes Res Clin Pract; 1994 Oct; 25(3):191-8. PubMed ID: 7851274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study.
    Salomaa VV; Tuomilehto J; Jauhiainen M; Korhonen HJ; Stengård J; Uusitupa M; Pitkanen M; Penttila I
    Diabetes Care; 1992 May; 15(5):657-65. PubMed ID: 1516486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
    Gonzélez C; Stern MP; Mitchell BD; Valdez RA; Haffner SM; Pérez BA
    Diabetes Care; 1994 May; 17(5):397-404. PubMed ID: 8062606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of micro- and macroalbuminuria in a Canarian population of type 2 diabetic patients. Relationship with blood pressure, lipid profile, obesity and metabolic control.
    De Pablos PL; Martinez J; Martinez MP; Doreste JA
    Diabetes Metab; 1998 Sep; 24(4):337-43. PubMed ID: 9805644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).
    Davis TM; Cull CA; Holman RR;
    Diabetes Care; 2001 Jul; 24(7):1167-74. PubMed ID: 11423497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK; Mohamed Ali V; Jain SK; Walji S; Yudkin JS
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UK Prospective Diabetes Study (UKPDS). X. Urinary albumin excretion over 3 years in diet-treated type 2, (non-insulin-dependent) diabetic patients, and association with hypertension, hyperglycaemia and hypertriglyceridaemia.
    Diabetologia; 1993 Oct; 36(10):1021-9. PubMed ID: 8243850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships of C-peptide levels and the C-peptide/bloodsugar ratio with clinical/biochemical variables associated with insulin resistance in orally-treated, well-controlled type 2 diabetic patients.
    Relimpio F; Losada F; Pumar A; García de Pesquera F; Morales F; Acosta D; Astorga R
    Diabetes Res Clin Pract; 1997 Jun; 36(3):173-80. PubMed ID: 9237784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of associated conditions on glycemic control of NIDDM patients.
    Ferrannini E; Stern MP; Galvan AQ; Mitchell BD; Haffner SM
    Diabetes Care; 1992 Apr; 15(4):508-14. PubMed ID: 1499466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients.
    Chan WB; Tong PC; Chow CC; So WY; Ng MC; Ma RC; Osaki R; Cockram CS; Chan JC
    Diabet Med; 2004 Apr; 21(4):349-53. PubMed ID: 15049937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of newly diagnosed non-insulin-dependent (type 2) diabetes mellitus: a retrospective audit.
    Marsiaj HI; Catalano C; Sum CF; Home PD; Alberti KG
    Diabetes Res Clin Pract; 1991 May; 12(2):129-36. PubMed ID: 1879304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.